Mottiwala Aziz

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mottiwala Aziz's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-19
S Sale
93,096 -36.7%
454.85
US$4,906,013 		93,096 -36.7% 454.85 US$4,906,013
2026-03-19 2026-03-19
PrS Proposed sale
4,910
453.54
US$2,742,615 		4,910 453.54 US$2,742,615
2026-03-19 2026-03-18
S Sale
96,373 +31.1%
181.91
US$3,741,995 		96,373 +31.1% 181.91 US$3,741,995
2026-03-18 2026-03-18
PrS Proposed sale
4,330
68.71
US$297,513 		4,330 68.71 US$297,513
2026-03-19 2026-03-17
S Sale
4,286 -5.8%
69.42
US$297,534 		4,286 -5.8% 69.42 US$297,534
2026-03-17 2026-03-17
PrS Proposed sale
4,286
69.41
US$297,511 		4,286 69.41 US$297,511
2025-06-11 2025-06-09
PlS Planned sale
17,500 -26.9%
43.76
US$765,800 		17,500 -26.9% 43.76 US$765,800
2025-06-09 2025-06-09
PrS Proposed sale
17,500
44.74
US$782,950 		17,500 44.74 US$782,950
2025-03-20 2025-03-20
PrS Proposed sale
3,365
50.11
US$168,632 		3,365 50.11 US$168,632
2025-03-20 2025-03-20
S Sale
3,365 -4.9%
50.11
US$168,620 		3,365 -4.9% 50.11 US$168,620
2025-03-20 2025-03-19
S Sale
3,557 -4.9%
47.40
US$168,602 		3,557 -4.9% 47.40 US$168,602
2025-03-19 2025-03-19
PrS Proposed sale
3,557
47.40
US$168,599 		3,557 47.40 US$168,599
2025-03-20 2025-03-18
S Sale
3,643 -4.8%
46.29
US$168,634 		3,643 -4.8% 46.29 US$168,634
2025-03-18 2025-03-18
PrS Proposed sale
3,643
46.28
US$168,614 		3,643 46.28 US$168,614
2024-03-19 2024-03-18
S Sale
4,766 -8.1%
30.60
US$145,840 		4,766 -8.1% 30.60 US$145,840
2024-03-18 2024-03-18
PrS Proposed sale
4,766
30.60
US$145,828 		4,766 30.60 US$145,828
2023-07-21 2023-07-19
PlS Planned sale
2,400 -5.0%
20.05
US$48,120 		2,400 -5.0% 20.05 US$48,120
2023-07-19 2023-07-19
PrS Proposed sale
2,400
20.05
US$48,110 		2,400 20.05 US$48,110
2023-06-12 2023-06-08
PlS Planned sale
100 -0.2%
20.00
US$2,000 		100 -0.2% 20.00 US$2,000
2023-06-08 2023-06-08
PrS Proposed sale
100
20.00
US$2,000 		100 20.00 US$2,000
2023-06-08 2023-06-07
PlS Planned sale
2,500 -4.9%
19.34
US$48,350 		2,500 -4.9% 19.34 US$48,350
2023-06-07 2023-06-07
PrS Proposed sale
2,500
19.34
US$48,343 		2,500 19.34 US$48,343
2023-06-08 2023-06-06
PlS Planned sale
2,143 -4.1%
18.61
US$39,881 		2,143 -4.1% 18.61 US$39,881
2023-06-06 2023-06-06
PrS Proposed sale
2,143
18.61
US$39,876 		2,143 18.61 US$39,876
2023-03-23 2023-03-23
S Sale
372 -0.7%
12.15
US$4,520 		372 -0.7% 12.15 US$4,520
2023-03-23 2023-03-22
S Sale
357 -0.7%
12.64
US$4,512 		357 -0.7% 12.64 US$4,512
2023-03-23 2023-03-21
S Sale
349 -0.6%
12.89
US$4,499 		349 -0.6% 12.89 US$4,499
2023-03-21 2023-03-20
S Sale
358 -0.7%
12.61
US$4,514 		358 -0.7% 12.61 US$4,514
2023-03-21 2023-03-17
S Sale
339 -0.6%
13.28
US$4,502 		339 -0.6% 13.28 US$4,502
2023-03-17 2023-03-16
S Sale
336 -0.6%
13.43
US$4,512 		336 -0.6% 13.43 US$4,512
2023-03-16 2023-03-16
PrS Proposed sale
2,160
13.66
US$29,506 		2,160 13.66 US$29,506
2022-11-17 2022-11-15
PlS Planned sale
6,857 -12.1%
17.72
US$121,506 		6,857 -12.1% 17.72 US$121,506
2021-11-10 2021-11-08
PlS Planned sale
1,889 -3.6%
28.11
US$53,100 		1,889 -3.6% 28.11 US$53,100
2021-11-08 2021-11-05
PlS Planned sale
11 -0.0%
28.11
US$309 		11 -0.0% 28.11 US$309
2021-11-08 2021-11-04
PlS Planned sale
100 -0.2%
28.03
US$2,803 		100 -0.2% 28.03 US$2,803
2021-11-04 2021-11-02
PlS Planned sale
542 -1.0%
27.07
US$14,672 		542 -1.0% 27.07 US$14,672
2021-11-04 2021-11-02
PlS Planned sale
5,458 -9.4%
26.75
US$146,018 		5,458 -9.4% 26.75 US$146,018
2021-09-14 2021-09-10
S Sale
2,593 -4.3%
22.15
US$57,435 		2,593 -4.3% 22.15 US$57,435